Literature DB >> 22211672

Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes.

Anna C Jacobs1, Khalid Sayood, Stephen B Olmsted, Catlyn E Blanchard, Steven Hinrichs, David Russell, Paul M Dunman.   

Abstract

Acinetobacter baumannii has emerged as a bacterial pathogen of considerable healthcare concern. Yet, little is known about the organism's basic biological processes and the regulatory networks that modulate expression of its virulence factors and antibiotic resistance. Using Affymetrix GeneChips , we comprehensively defined and compared the transcriptomes of two A. baumannii strains, ATCC 17978 and 98-37-09, during exponential and stationary phase growth in Luria-Bertani (LB) medium. Results revealed that in addition to expected growth phase-associated metabolic changes, several putative virulence factors were dramatically regulated in a growth phase-dependent manner. Because a common feature between the two most severe types of A. baumannii infection, pneumonia and septicemia, includes the organism's dissemination to visceral organs via the circulatory system, microarray studies were expanded to define the expression properties of A. baumannii during growth in human serum. Growth in serum significantly upregulated iron acquisition systems, genes associated with epithelial cell adherence and DNA uptake, as well as numerous putative drug efflux pumps. Antibiotic susceptibility testing verified that the organism exhibits increased antibiotic tolerance when cultured in human serum, as compared to LB medium. Collectively, these studies provide researchers with a comprehensive database of A. baumannii's expression properties in LB medium and serum and identify biological processes that may contribute to the organism's virulence and antibiotic resistance.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22211672     DOI: 10.1111/j.1574-695X.2011.00926.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  28 in total

1.  Serum Albumin and Ca2+ Are Natural Competence Inducers in the Human Pathogen Acinetobacter baumannii.

Authors:  German Matias Traglia; Brettni Quinn; Sareda T J Schramm; Alfonso Soler-Bistue; Maria Soledad Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

Review 2.  The Secrets of Acinetobacter Secretion.

Authors:  Brent S Weber; Rachel L Kinsella; Christian M Harding; Mario F Feldman
Journal:  Trends Microbiol       Date:  2017-02-16       Impact factor: 17.079

3.  Optimization of 4-Substituted Benzenesulfonamide Scaffold To Reverse Acinetobacter baumannii Serum-Adaptive Efflux Associated Antibiotic Tolerance.

Authors:  Michaelle Chojnacki; Xufeng Cao; Mikaeel Young; Rebecca N Fritz; Paul M Dunman; Daniel P Flaherty
Journal:  ChemMedChem       Date:  2020-08-13       Impact factor: 3.466

4.  Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors.

Authors:  Catlyn Blanchard; Pamela Barnett; Jessamyn Perlmutter; Paul M Dunman
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

Review 5.  Intravenous Minocycline: A Review in Acinetobacter Infections.

Authors:  Sarah L Greig; Lesley J Scott
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

6.  An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action.

Authors:  Alberto Oddo; Thomas T Thomsen; Susanne Kjelstrup; Ciara Gorey; Henrik Franzyk; Niels Frimodt-Møller; Anders Løbner-Olesen; Paul R Hansen
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

7.  In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii.

Authors:  Luísa C S Antunes; Francesco Imperi; Fabrizia Minandri; Paolo Visca
Journal:  Antimicrob Agents Chemother       Date:  2012-09-10       Impact factor: 5.191

Review 8.  Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.

Authors:  Bora Shin; Woojun Park
Journal:  J Microbiol       Date:  2017-10-27       Impact factor: 3.422

9.  Effect of Host Human Products on Natural Transformation in Acinetobacter baumannii.

Authors:  Brettni Quinn; German M Traglia; Meaghan Nguyen; Jasmine Martinez; Christine Liu; Jennifer S Fernandez; Maria Soledad Ramirez
Journal:  Curr Microbiol       Date:  2018-01-13       Impact factor: 2.188

Review 10.  Uncovering the mechanisms of Acinetobacter baumannii virulence.

Authors:  Christian M Harding; Seth W Hennon; Mario F Feldman
Journal:  Nat Rev Microbiol       Date:  2017-12-18       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.